Literature DB >> 12452618

Daily variability of serum prostate-specific antigen in men over 50 years of age.

A Tekin1, N Atsu, H Ozen.   

Abstract

In order to investigate the variability of serum prostate-specific antigen (PSA) levels a total of 44 men 50 years or older with normal digital rectal examination were enrolled. Blood samples were obtained three times within a day, and, immediately before and 72 hours after hospitalisation. Alterations in serum PSA value during the day and after hospitalisation, which might affect clinical decision, occurred in 15% of the cases with borderline PSA values. The results indicate that there may be significant changes in serum PSA levels within a day and after hospitalisation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 12452618     DOI: 10.1023/a:1020583203777

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  14 in total

1.  Spontaneous circadian fluctuations of prostate specific antigen and prostatic acid phosphatase serum activities in patients with prostatic cancer.

Authors:  D Mannini; P Maver; E Aiello; G Corrado; F Vecchi; B Bellanova; M Marengo
Journal:  Urol Res       Date:  1988

2.  Analytical and physiological characteristics of prostate-specific antigen and prostatic acid phosphatase in serum compared.

Authors:  R B Schifman; F R Ahmann; A Elvick; M Ahmann; K Coulis; M K Brawer
Journal:  Clin Chem       Date:  1987-11       Impact factor: 8.327

3.  Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate.

Authors:  T A Stamey; N Yang; A R Hay; J E McNeal; F S Freiha; E Redwine
Journal:  N Engl J Med       Date:  1987-10-08       Impact factor: 91.245

4.  The role of prostate specific antigen as a tumor marker in men with advanced adenocarcinoma of the prostate.

Authors:  T J Maatman
Journal:  J Urol       Date:  1989-06       Impact factor: 7.450

Review 5.  Prostate specific antigen: a critical assessment of the most useful tumor marker for adenocarcinoma of the prostate.

Authors:  J E Oesterling
Journal:  J Urol       Date:  1991-05       Impact factor: 7.450

6.  The impact of ejaculation on serum prostate specific antigen.

Authors:  R Simak; S Madersbacher; Z F Zhang; U Maier
Journal:  J Urol       Date:  1993-09       Impact factor: 7.450

Review 7.  Analysis of variation in prostate-specific antigen values.

Authors:  M Riehmann; P R Rhodes; T D Cook; G S Grose; R C Bruskewitz
Journal:  Urology       Date:  1993-10       Impact factor: 2.649

8.  Daily variability in human serum prostate-specific antigen and prostatic acid phosphatase: a comparative evaluation.

Authors:  S W Dejter; J S Martin; R A McPherson; J H Lynch
Journal:  Urology       Date:  1988-10       Impact factor: 2.649

9.  Physiologic (intraindividual) variation of serum prostate-specific antigen in 814 men from a screening population.

Authors:  K Komatsu; N Wehner; A F Prestigiacomo; Z Chen; T A Stamey
Journal:  Urology       Date:  1996-03       Impact factor: 2.649

10.  Comparison of prostate specific antigen concentration versus prostate specific antigen density in the early detection of prostate cancer: receiver operating characteristic curves.

Authors:  W J Catalona; J P Richie; J B deKernion; F R Ahmann; T L Ratliff; B L Dalkin; L R Kavoussi; M T MacFarlane; P C Southwick
Journal:  J Urol       Date:  1994-12       Impact factor: 7.450

View more
  3 in total

1.  Effect of heamolysis on prostate-specific antigen.

Authors:  Hasan S Sağlam; Osman Köse; Fatma Ozdemir; Oztuğ Adsan
Journal:  ISRN Urol       Date:  2012-12-01

2.  Hospitalization decreases serum prostate-specific antigen values compared with outpatient values in patients with benign prostatic diseases.

Authors:  In Seok Yoon; Tae Young Shin; Sun Il Kim; Seong Kon Park; Hyun Ik Jang; Jong Bo Choi; Hyun Soo Ahn; Young Soo Kim; Se Joong Kim
Journal:  Korean J Urol       Date:  2013-09-10

3.  A population study of fasting time and serum prostate-specific antigen (PSA) level.

Authors:  Cheryl K Lau; Maggie Guo; Jeannine A Viczko; Christopher T Naugler
Journal:  Asian J Androl       Date:  2014 Sep-Oct       Impact factor: 3.285

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.